Furthermore, VP may partly bypass YAP and target IL-6 directly or via other pathways, as the tumor-inhibitory effects of VP were reported to be YAP-independently (Zhang et al., 2015; Dasari et al., 2017). This evidence concerns the gene IL6 and neoplasm.